Lilly, Medtronic ink marketing diabetes pact
Eli Lilly and Medtronic have formed a strategic marketing collaboration to improve the delivery of diabetes education for people and caregivers affected by type 1 diabetes in the U.S.

This includes the development of new educational resources and classes around the initiation and intensive management of insulin, insulin pump therapy and continuous glucose monitoring (CGM).

The alliance combines the insulin experience of Lilly and diabetes technologies of Medtronic, a manufacturer of insulin pumps and CGM and maker of the integrated diabetes management system that combines insulin pump therapy with CGM.